Description

PT-141 (Bremelanotide) is a synthetic peptide that works directly on the brain’s melanocortin receptors to boost sexual desire and arousal rather than affecting blood flow.

In women, it increases libido and subjective sexual satisfaction, making it an FDA-approved treatment for Hypoactive Sexual Desire Disorder (HSDD).

In men, it enhances sexual drive and helps trigger erections, offering an effective alternative for those who don’t respond well to traditional medications like Viagra. Unlike vascular treatments, its unique central nervous system mechanism targets the psychological and neurological drivers of intimacy for both sexes. Typically administered as a subcutaneous injection, it is used on an as-needed basis shortly before sexual activity.